Berkeley teams up with Novartis in $50m plant genomics deal

Colin Macilwain

Nature, 1998, vol. 396, issue 6706, 5-5

Abstract: washington The University of California at Berkeley is poised to strike a unique agreement with the Swiss drug company Novartis.

Date: 1998
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/23772 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:396:y:1998:i:6706:d:10.1038_23772

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/23772

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().